Editor's Note Despite high rates of patients discharged with cardioprotective medications, the long-term burden of postoperative myocardial infarction (MI) after major vascular surgery is substantial, with a high mortality rate in the following year, this study finds. Of 26,231 vascular surgery patients analyzed, factors linked to an increased risk of postoperative…

Read More

Editor's Note In this French study, the risk of postoperative pulmonary embolism was elevated beyond 6 weeks regardless of the type of procedure. This analysis of 60,703 patients who had one of six types of surgery (ie, vascular, GYN, GI, hip or knee replacement, fractures, and other orthopedic procedures) found…

Read More

Editor's Note In response to an increase in adverse events related to direct oral anticoagulants (DOACs), the Joint Commission, on July 31, issued a new Sentinel Event Alert on managing DOAC risks. The alert: provides guidance for safe use and management of DOACs stresses understanding the risks, benefits, side effects,…

Read More

Editor's Note The Joint Commission on January 23 announced that it is reinstating the individual mechanical thrombectomy volume eligibility requirement for the Thrombectomy-Capable Stroke Center (TSC) and Comprehensive Stroke Center (CSC) certification programs. The Joint Commission is also implementing a revised volume requirement in 6 months that expands which physicians…

Read More

Editor's Note The Joint Commission on November 28 announced that it had revised National Patient Safety Goal (NPSG) 03.05.01. The revisions apply to organizations that initiate, manage, and adjust dosage for anticoagulant medications, including accredited ambulatory health care (in medical centers only), hospitals, critical access hospitals, and nursing care centers.…

Read More

Editor's Note The Joint Commission announced on June 20 that it is seeking comments on proposed changes to the National Patient Safety Goal (NPSG) 03.05.01 on reducing harm from anticoagulant therapy. Revised requirements, which will address the use of new direct oral anticoagulant medications, include: drug selection dosing and monitoring…

Read More

Editor's Note In this study, perioperative red blood cell (RBC) transfusions were significantly associated with development of new or progressive postoperative venous thromboembolism (VTE) within 30 days of a surgical procedure. Of 750,937 patients included in the analysis, 47,410 (6.3%) received at lest one perioperative RBC transfusion. Of these, 6,309…

Read More

Editor's Note The Joint Commission on March 21 announced that the first hospital to earn its Thrombectomy-Capable Stroke Center (TSC) certification is St Joseph Mercy Oakland, Pontiac, Michigan, a member of Saint Joseph Mercy Health System. In collaboration with the American Heart Association/American Stroke Association (AHA/ASA), the TSC certification signifies…

Read More

Editor's Note A new report from the Agency for Healthcare Research and Quality (AHRQ) compares the effectiveness of strategies to prevent venous thromboembolism (VTE) in patients having total hip replacement (THR), total knee replacement (TKR), or hip fracture surgery. The study directly compares different types of blood thinners and mechanical…

Read More

Editor's Note The Joint Commission on June 21 announced its new, free venous thromboembolism (VTE) compendium of resources. The compendium was developed to help clinicians, healthcare educators, and other healthcare professionals provide reliable and up-to-date patient education materials for VTE and anticoagulation therapy. Joint Commission Online Weekly Newsletter

Read More